Johnson & Johnson (JNJ)
148.95
+0.23
(+0.15%)
USD |
NYSE |
May 08, 16:00
148.90
-0.05
(-0.03%)
Pre-Market: 08:46
Johnson & Johnson Gross Profit (TTM): 61.53B for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 61.53B |
December 31, 2023 | 60.87B |
September 30, 2023 | 60.12B |
June 30, 2023 | 59.20B |
March 31, 2023 | 57.99B |
December 31, 2022 | 59.61B |
September 30, 2022 | 54.02B |
June 30, 2022 | 56.28B |
March 31, 2022 | 55.91B |
December 31, 2021 | 55.34B |
September 30, 2021 | 61.73B |
June 30, 2021 | 59.75B |
March 31, 2021 | 55.79B |
December 31, 2020 | 54.16B |
September 30, 2020 | 53.11B |
June 30, 2020 | 52.86B |
March 31, 2020 | 54.73B |
December 31, 2019 | 54.50B |
September 30, 2019 | 54.32B |
June 30, 2019 | 54.22B |
March 31, 2019 | 54.50B |
December 31, 2018 | 54.49B |
September 30, 2018 | 53.99B |
June 30, 2018 | 52.96B |
March 31, 2018 | 52.05B |
Date | Value |
---|---|
December 31, 2017 | 51.01B |
September 30, 2017 | 50.54B |
June 30, 2017 | 50.15B |
March 31, 2017 | 50.30B |
December 31, 2016 | 50.10B |
September 30, 2016 | 49.77B |
June 30, 2016 | 49.32B |
March 31, 2016 | 48.60B |
December 31, 2015 | 48.54B |
September 30, 2015 | 48.80B |
June 30, 2015 | 49.99B |
March 31, 2015 | 51.02B |
December 31, 2014 | 51.58B |
September 30, 2014 | 51.58B |
June 30, 2014 | 50.75B |
March 31, 2014 | 49.68B |
December 31, 2013 | 48.97B |
September 30, 2013 | 48.12B |
June 30, 2013 | 47.35B |
March 31, 2013 | 46.29B |
December 31, 2012 | 45.57B |
September 30, 2012 | 44.93B |
June 30, 2012 | 44.41B |
March 31, 2012 | 44.50B |
December 31, 2011 | 44.67B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
52.86B
Minimum
Jun 2020
61.73B
Maximum
Sep 2021
56.80B
Average
55.85B
Median
Gross Profit (TTM) Benchmarks
Amgen Inc | 19.60B |
Eli Lilly and Co | 28.80B |
Merck & Co Inc | 45.66B |
Pfizer Inc | 31.64B |
Shockwave Medical Inc | 685.44M |